The DOI matches its Crossref record; 190 of the 194 references it cites were found in a registry or an index; 91 of the 133 sources its claims cite were checked for support.
Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories
Open accessAbstract
In a subset of patients, chronic exposure to stress is an etiological risk factor for neuroinflammation and depression. Neuroinflammation affects up to 27% of patients with MDD and is associated with a more severe, chronic, and treatment-resistant trajectory. Inflammation is not unique to depression and has transdiagnostic effects suggesting a shared etiological risk factor underlying psychopathologies and metabolic disorders. Research supports an association but not necessarily a causation with depression. Putative mechanisms link chronic stress to dysregulation of the HPA axis and immune cell glucocorticoid resistance resulting in hyperactivation of the peripheral immune system. The chronic extracellular release of DAMPs and immune cell DAMP-PRR signaling creates a feed forward loop that accelerates peripheral and central inflammation. Higher plasma levels of inflammatory cytokines, most consistently interleukin IL-1β, IL-6, and TNF-α, are correlated with greater depressive symptomatology. Cytokines sensitize the HPA axis, disrupt the negative feedback loop, and further propagate inflammatory reactions. Peripheral inflammation exacerbates central inflammation (neuroinflammation) through several mechanisms including disruption of the blood-brain barrier, immune cellular trafficking, and activation of glial cells. Activated glial cells release cytokines, chemokines, and reactive oxygen and nitrogen species into the extra-synaptic space dysregulating neurotransmitter systems, imbalancing the excitatory to inhibitory ratio, and disrupting neural circuitry plasticity and adaptation. In particular, microglial activation and toxicity plays a central role in the pathophysiology of neuroinflammation. Magnetic resonance imaging (MRI) studies most consistently show reduced hippocampal volumes. Neural circuitry dysfunction such as hypoactivation between the ventral striatum and the ventromedial prefrontal cortex underlies the melancholic phenotype of depression. Chronic administration of monoamine-based antidepressants counters the inflammatory response, but with a delayed therapeutic onset. Therapeutics targeting cell mediated immunity, generalized and specific inflammatory signaling pathways, and nitro-oxidative stress have enormous potential to advance the treatment landscape. Future clinical trials will need to include immune system perturbations as biomarker outcome measures to facilitate novel antidepressant development. In this overview, we explore the inflammatory correlates of depression and elucidate pathomechanisms to facilitate the development of novel biomarkers and therapeutics.
Overview
CoChat Summary
TL;DR
This narrative review links chronic stress to HPA-axis dysregulation, immune-cell glucocorticoid resistance, DAMP-PRR signaling, peripheral and central inflammation, and depression. It argues that neuroinflammation defines a severe, treatment-resistant depressive subtype and reviews emerging anti-inflammatory and targeted immunomodulatory treatments.
Key findings
- Neuroinflammation affects up to 27% of patients with MDD and is associated with a more severe, chronic, treatment-resistant trajectory; peripheral CRP >3 mg/L is commonly used to subtype inflammation and correlates with CSF CRP.
- Chronic stress is proposed to drive HPA-axis dysregulation and glucocorticoid resistance, with elevated IL-1β, IL-6, and TNF-α; in preclinical work, peripheral IL-6 was 27 times higher in susceptible versus resilient mice after repeated social defeat stress, and anti-IL-6 before stress prevented social avoidance.
- Central effects include BBB disruption, glial activation, and neurotransmitter/network dysfunction; a meta-analysis estimated an 18% increase in TSPO availability in depressed patients, minocycline improved depression with effect sizes as high as 0.71, and MRI most consistently shows reduced hippocampal volumes.
- Anti-inflammatory augmentation may help: adjunctive anti-inflammatory treatment was reported as 52% more effective than placebo, celecoxib plus sertraline made response 7 times more likely, anti-cytokine treatment had a moderate effect size (Cohen’s d = 0.40), and infliximab reduced HAM-D at week 12 in patients with baseline CRP >5 mg/L.
Methods
- Narrative overview of pathophysiological mechanisms and emerging anti-inflammatories; no primary data collection or systematic review protocol is described.
- Synthesizes preclinical animal models, clinical observational studies, postmortem and neuroimaging findings, randomized trials, and meta-analyses.
- Main analysis is qualitative synthesis, with tables summarizing inflammatory mediators, proposed roles, and emerging therapeutic targets.
Limitations
- The paper states that evidence linking chronic stress, inflammation, and depression is largely observational and supports association but not necessarily causation.
- It states that anti-inflammatory data interpretation is limited by small numbers of studies, moderate to large heterogeneity, variations in diagnostic and treatment planning, and inclusion of patients without evidence of inflammation; targeted therapies are mostly limited to animal models or patients with autoimmune/rheumatological conditions.
- Evident from the text: as a narrative review, it does not describe a systematic search strategy, formal risk-of-bias assessment, or quantitative pooling of the reviewed literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
87 Valid · 8 Not valid · 42 Not checked · 27 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, persistent stress overstimulates the HPA axis causing an excess release of cortisol.”
§ Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories > Hypothalamic–pituitary–adrenal axis
What the sources say
- Supportedcites [16] Mikulska, 2021, HPA Axis in the Pathomechanism of depression and schizophrenia: new therapeutic strategies based on its participation, Brain Sci source
Section 7 states that chronic stress is associated with excessive activation of the HPA axis and that activation culminates in cortisol secretion. Section 3 also links chronic stress to elevated cortisol levels through HPA-axis dysregulation. (LLM, conf=0.92)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Clinical studies have corroborated that depressed patients have higher serum levels of IL-1β compared to non-depressed patients.”
§ Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories > Pattern-recognition receptors > NLRP3
What the sources say
- Partly supportedcites [51] Ferentinos, 2021, Interleukin-1 Beta in peripheral blood mononuclear cell lysates as a longitudinal biomarker of response to antidepressants: a pilot study, Front Psych sourceExperimental — accuracy not yet measured
The Discussion reports that a meta-analysis found higher circulating IL-1β in patients with major depressive disorder, but only among high-quality studies; it also says other meta-analyses found no significant difference. This study measured plasma rather than serum, and its Results found no significant patient–control difference in plasma IL-1β. It therefore does not support the unqualified claim about higher serum levels. (LLM, conf=0.86)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A meta-analysis reported higher levels of serum pro-inflammatory cytokines (IL-1β, IL-2, IL-6, IL-12, TNF-α) and reduced anti-inflammatory cytokines (IL-4, IL-10, transforming growth factor [TGF]-β1) in depressed compared to non-depressed patients (62).”
§ Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories > Cytokines
What the sources say
- Partly supportedcites [62] Osimo, 2020, Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls, Brain Behav Immun sourceExperimental — accuracy not yet measured
The Results (Mean differences) report higher IL-1β, IL-2, IL-6, IL-12 and TNF-α, and lower IL-4, in patients with depression than in controls. But they report higher—not lower—IL-10 and no significant difference in TGF-β, so the claimed reductions in those two markers are not supported. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Approximately 30% of patients with hepatitis C develop major depression within the first 3 months of receiving IFN-α (63).”
§ Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories > Cytokines
What the sources say
- Partly supportedcites [63] Chiu, 2017, Recurrence of depressive disorders after interferon-induced depression, Transl Psychiatry sourceExperimental — accuracy not yet measured
The Introduction says that up to 30% of IFN-α-treated patients with hepatitis C develop a major depressive episode within the first three months. The citing sentence preserves the population, condition and timing, but “approximately 30%” presents the source’s upper bound as an approximate rate. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The NLR3P inflammasome mediates proteolytic cleave of pro-caspase-1 leading to activation of caspase-1, which cleaves pro-interleukin 1β and 18 into their active cytokine forms (47).”
§ Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories > Pattern-recognition receptors > NLRP3
What the sources say
- Supportedcites [47] Guo, 2015, Inflammasomes: mechanism of action, role in disease, and therapeutics, Nat Med source
The NLRP3 inflammasome section says that pro-caspase-1 undergoes auto-proteolytic maturation into active caspase-1. The Introduction says active caspase-1 cleaves IL-1-family precursors into bioactive IL-1β and IL-18. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
99 more claims · 56 with their cited sources checked
Create a free account to see all 164 claims and every source verdict.
- It may state two separate claims as one. 50
- Probably not a substantial claim. 11
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories > Cytokines
“Yamano and colleagues reversed INF-α induced stress susceptibility in mice with a corticotropin-releasing hormone receptor antagonist in a dose dependent fashion, suggesting that overactivity of the HPA axis mediates the cytokine depression response (64).”
§ Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories > References
“64. Yamano M Tohyama M. Distribution of corticotropin-releasing factor and calcitonin gene-related peptide in the developing mouse cerebellum.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories > Damage-associated molecular patterns > S100B
“A 12-week randomized, placebo-controlled study found that pioglitazone, an insulin-sensitizing drug, improved glucose control and reduced chronic depression in patients with type II diabetes (28).”
§ Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories > References
“28. Li X Wilder-Smith CH Kan ME Lu J Cao Y Wong RK. Combat-training stress in soldiers increases S100B, a marker of increased blood-brain-barrier permeability, and induces immune activation.”
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931 · cited 1×
“Activated macrophages and microglia release ROS that disrupt cell membranes, cellular DNA, and protein synthesis (101).”
BackgroundNitric oxide synthases: regulation and function
Forstermann, U., & Sessa, W. C. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr304 · Cited by 4,409 · cited 1×
“Nitrosative stress occurs when there is an abnormal increase in the level of nitric oxide (NO) produced by the inducible isoenzymes of NO synthase: neuronal, inducible, and endothelial (113).”
BackgroundThe NLRP3 Inflammasome: an overview of mechanisms of activation and regulation
Kelley, N., Jeltema, D., Duan, Y., & He, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133328 · Cited by 3,539 · cited 2×
“NLRP3 inflammasome (48) NLRP3 mediates proteolytic cleave of procaspase-1 leading to activation of caspase 1, IL-1β”
BackgroundDifferentiation of Effector CD4 T Cell Populations
Zhu, J., Yamane, H., & Paul, W. E. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101212 · Cited by 3,452 · cited 1×
“Treg cells suppress the immune response whereas Th cells trigger immunological responses (65).”
BackgroundInflammasomes: mechanism of action, role in disease, and therapeutics
Guo, H., Callaway, J. B., & Ting, J. P.-Y. (2015) · Nature Medicine · doi:10.1038/nm.3893 · Cited by 3,340 · cited 2×
“Several PRRs, toll-like receptor-4 (TLR-4) and NLR family pyrin domain containing 3 (NLRP3), have been implicated in depression (47).”
BackgroundMechanisms, regulation and functions of the unfolded protein response
Hetz, C., Zhang, K., & Kaufman, R. J. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0250-z · Cited by 2,666 · cited 1×
“The function of the endoplasmic reticulum (ER) is to properly fold proteins and traffic them to various organelles and the cell membrane (37).”
BackgroundThe blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661 · cited 1×
“BMECs are connected to each other by tight junctions, GAP junctions, and adherens junctions (82).”
BackgroundThe Bidirectional Relationship of Depression and Inflammation: Double Trouble
Beurel, E., Toups, M., & Nemeroff, C. B. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.002 · Cited by 2,136 · cited 1×
“Modulation of NF-κB signaling is currently being investigated as an approach to treat major depression (80).”
BackgroundMarine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance
Calder, P. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.010 · Cited by 1,717 · cited 1×
“EPA and DHA ameliorate inflammation by inhibiting leukocyte chemotaxis, adhesion molecule expression, and the production of inflammatory cytokines and prostaglandins (164).”
BackgroundRaison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617 · cited 19×
“Specifically, antibodies against TNF-alpha (Adalimumab, etanercept, infliximab) and IL-6 (tocilizumab) showed statistically significant improvements in depressive symptoms (173).”
BackgroundInfluentialThe stressed synapse: the impact of stress and glucocorticoids on glutamate transmission
Popoli, M., Yan, Z., McEwen, B. S., & Sanacora, G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3138 · Cited by 1,393 · cited 1×
“Somatostatin regulates ACTH secretion and loss of somatostatinexpressing interneurons increases glucocorticoid signaling and glutamate neurotransmission in the hippocampus (147).”
BackgroundChildhood maltreatment predicts adult inflammation in a life-course study
Danese, A., Pariante, C. M., Caspi, A., Taylor, A., & Poulton, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610362104 · Cited by 1,264 · cited 2×
“Several pathways to cross the BBB have been described: (1) Entering the brain parenchyma through leaky capillaries in the circumventricular organs and choroid plexus, (2) Direct transportation into the CNS, (3) Binding to vagal afferents and entering the brain, and (4) Direct cellular trafficking (84).”
BackgroundMethodDamage-associated molecular patterns in inflammatory diseases
Roh, J. S., & Sohn, D. H. (2018) · Immune Network · doi:10.4110/in.2018.18.e27 · Cited by 1,261 · cited 1×
“Studies have focused on S100 proteins, HSPs, and Gal-3 because of their pathogenic immunoregulatory roles in comorbid inflammatory diseases (24).”
BackgroundSocial stress induces neurovascular pathology promoting depression
Menard, C., Pfau, M. L., Hodes, G. E., Kana, V., Wang, V. X., Bouchard, S., Takahashi, A., Flanigan, M. E., Aleyasin, H., LeClair, K. B., et al. (2017) · Nature Neuroscience · doi:10.1038/s41593-017-0010-3 · Cited by 1,028 · cited 2×
“Chronic administration of imipramine normalized claudin-5 mRNA expression in the nucleus accumbens and reversed depressive behaviors in stress susceptible mice (81).”
BackgroundDuman, R. S., Sanacora, G., & Krystal, J. H. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.013 · Cited by 1,026 · cited 1×
“Newer treatments are focusing on restoring the glutamate and GABAergic neurotransmission balance (151).”
BackgroundHaroon, E., Raison, C. L., & Miller, A. H. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.205 · Cited by 1,000
Sohal, V. S., & Rubenstein, J. L. R. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0426-0 · Cited by 988 · cited 1×
“Synchronization of the excitatory to inhibitory (E/I) ratio is important for balancing the signal-to-noise ratio in neural circuits, and reduced inhibition leads to noisier circuits and less efficient information processing (148).”
BackgroundKöhler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O., & Krogh, J. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1611 · Cited by 941 · cited 9×
“IDO enzyme inhibitors QUIN (138) Overstimulates the NMDA receptor resulting in glutamatergic excitotoxicity GSK-3β inhibitors COX-2 (155) COX-2 increases PGE-2 resulting in glutamatergic excitability, stimulation of CRF, and the release of pro-inflammatory cytokines COX-2 inhibitors Proteoglycans (152) Reactive astroc…”
BackgroundInfluentialSetiawan, E., Wilson, A. A., Mizrahi, R., Rusjan, P. M., Miler, L., Rajkowska, G., Suridjan, I., Kennedy, J. L., Rekkas, P. V., Houle, S., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2427 · Cited by 939 · cited 1×
“PET imaging studies have found an increased uptake of TSPO ligands in the prefrontal cortex, anterior cingulate cortex, and the hippocampal formation in depressed compared to non-depressed patients indicating that microglial activation leads to neuroinflammation (92).”
Osimo, E. F., Pillinger, T., Rodriguez, I. M., Khandaker, G. M., Pariante, C. M., & Howes, O. D. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.02.010 · Cited by 937 · cited 4×
“Monoclonal antibodies to TNF-α IL-1β (50) IL-1β increases the release of TNF-α and IL-6 IL-1β receptor antagonists IL-2 (67) IL-2 differentiates Th1 and Th2 effector cells IL-2 antibodies IL-6 (11) IL-6 increases the production of acute phase proteins and neutrophils and differentiates B an T cell proliferation Anti-I…”
BackgroundResultInfluentialAstrocyte reactivity and reactive astrogliosis: costs and benefits
Pekny, M., & Pekna, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00041.2013 · Cited by 934 · cited 1×
“The proinflammatory cytokines and chemokines trigger gliosis, a neuro-immune response manifested by the proliferation and hypertrophy of glial cells (astrocytes, microglia, and oligodendrocytes) (88).”
BackgroundLassale, C., Batty, G. D., Baghdadli, A., Jacka, F., Sánchez-Villegas, A., Kivimäki, M., & Akbaraly, T. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0237-8 · Cited by 931
Microglia polarization from M1 to M2 in neurodegenerative diseases
Guo, S., Wang, H., & Yin, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.815347 · Cited by 920 · cited 1×
“During inflammation, microglia polarize toward the M1 phenotype, releasing proinflammatory cytokines and excessive glutamate (90).”
BackgroundMiller, A. H., Haroon, E., Raison, C. L., & Felger, J. C. (2013) · Depression and Anxiety · doi:10.1002/da.22084 · Cited by 892 · cited 2×
“Pro-inflammatory cytokines cross the BBB or are produced by neuronal cells dysregulating neurotransmission and neurocircuitry (61).”
BackgroundIL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress
Koo, J. W., & Duman, R. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708092105 · Cited by 862 · cited 1×
“IL-1β inhibits hippocampal neurogenesis and contributes to diminishing hedonic responses in susceptible animal models (49).”
BackgroundOsimo, E. F., Baxter, L. J., Lewis, G., Jones, P. B., & Khandaker, G. M. (2019) · Psychological Medicine · doi:10.1017/s0033291719001454 · Cited by 774 · cited 8×
“There is no unifying diagnostic criteria for depression associated with inflammation, however a peripheral C-reactive protein (CRP) level exceeding 3 mg/L is commonly used as a marker of subtyping inflammation (8).”
BackgroundInfluentialGoshen, I., Kreisel, T., Ben-Menachem-Zidon, O., Licht, T., Weidenfeld, J., Ben-Hur, T., & Yirmiya, R. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002055 · Cited by 762 · cited 1×
“The data suggests that adrenocortical activation mediates the relationship between IL-1 and stress-induced depression (12).”
BackgroundHodes, G. E., Pfau, M. L., Leboeuf, M., Golden, S. A., Christoffel, D. J., Bregman, D., Rebusi, N., Heshmati, M., Aleyasin, H., Warren, B. L., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415191111 · Cited by 692 · cited 19×
“Moreover, Kim and colleagues found that macrophage cell lines treated with tunicamycin increased the expression of ER stress markers, GRP94 and GRP78, and secretion of IL-6 (40).”
BackgroundInfluentialKappelmann, N., Lewis, G., Dantzer, R., Jones, P. B., & Khandaker, G. M. (2018) · Molecular Psychiatry · doi:10.1038/mp.2016.167 · Cited by 659 · cited 1×
“Specifically, antibodies against TNF-alpha (Adalimumab, etanercept, infliximab) and IL-6 (tocilizumab) showed statistically significant improvements in depressive symptoms (173).”
BackgroundDepression and sickness behavior are Janus-faced responses to shared inflammatory pathways
Maes, M., Berk, M., Goehler, L., Song, C., Anderson, G., Gałecki, P., & Leonard, B. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-66 · Cited by 629 · cited 2×
“Peripheral CRP levels exceeding 3 mg/l are associated with a specific depressive phenotype resembling “sickness behavior”: anhedonia, apathy, decreased appetite, fatigue, sleepiness, pain, suicidality, and cognitive impairments (5).”
BackgroundNeuroimmune mechanisms of depression
Hodes, G. E., Kana, V., Menard, C., Merad, M., & Russo, S. J. (2015) · Nature Neuroscience · doi:10.1038/nn.4113 · Cited by 585 · cited 1×
“Peripheral levels of IL-1β, IL-6, and TNF-α are consistently upregulated in susceptible animal models (10).”
BackgroundMolecular pathways of major depressive disorder converge on the synapse
Fries, G. R., Saldana, V. A., Finnstein, J., & Rein, T. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01806-1 · Cited by 504 · cited 2×
“Several DAMPs have been implicated in depression, including high mobility group box-1 (HMGB-1), extracellular ATP, purine bases and metabolites, heat shock proteins (HSPs), S100 proteins, and galectin- 3 (Gal-3) (23).”
BackgroundSarandol, A., Sarandol, E., Eker, S. S., Erdinc, S., Vatansever, E., & Kirli, S. (2007) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.829 · Cited by 486 · cited 1×
“The brain’s high consumption of oxygen makes it particularly vulnerable to oxidative stress compared to other organs and tissues (100).”
BackgroundA Meta-analysis of oxidative stress markers in depression
Liu, T., Zhong, S., Liao, X., Chen, J., He, T., Lai, S., & Jia, Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138904 · Cited by 485 · cited 1×
“Studies have reported higher levels of oxidative stress byproducts and lower levels of antioxidant enzymes (103).”
BackgroundLower synaptic density is associated with depression severity and network alterations
Holmes, S. E., Scheinost, D., Finnema, S. J., Naganawa, M., Davis, M. T., DellaGioia, N., Nabulsi, N., Matuskey, D., Angarita, G. A., Pietrzak, R. H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09562-7 · Cited by 484 · cited 1×
“Greater symptoms of depression are associated with reduced radioligand binding to SV2A in the dorsolateral prefrontal cortex, anterior cingulate cortex, and hippocampal regions (141).”
BackgroundKhanzode, S. D., Dakhale, G. N., Khanzode, S. S., Saoji, A., & Palasodkar, R. (2003) · Redox Report · doi:10.1179/135100003225003393 · Cited by 458 · cited 2×
“Therefore, modulation of NO signaling is a potential therapeutic target for MDD. Nagele and colleagues found that inhaled N2O at a concentration of either 25% or 50% significantly reduced scores on the Hamilton Depression Rating Scale (HDRS) at week 2 in patients with treatment resistant depression.”
BackgroundMikulska, J., Juszczyk, G., Gawrońska-Grzywacz, M., & Herbet, M. (2021) · Brain Sciences · doi:10.3390/brainsci11101298 · Cited by 450 · cited 2×
“HPA-axis (16) Overproduction of glucocorticoids elicits immune cells to release pro-inflammatory cytokines Vasopressin 1 b receptor antagonists Cortisol”
BackgroundWhat does plasma CRP tell us about peripheral and central inflammation in depression?
Felger, J. C., Haroon, E., Patel, T. A., Goldsmith, D. R., Wommack, E. C., Woolwine, B. J., Le, N.-A., Feinberg, R., Tansey, M. G., & Miller, A. H. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0096-3 · Cited by 448 · cited 1×
“Peripheral CRP levels strongly correlate with CSF CRP levels and are a reliable marker of neuroinflammation (9).”
BackgroundInflammation and depression: a causal or coincidental link to the pathophysiology?
Leonard, B. E. (2018) · Acta Neuropsychiatrica · doi:10.1017/neu.2016.69 · Cited by 409
Kynurenines in CNS disease: regulation by inflammatory cytokines.
Campbell, B. M., Charych, E., Lee, A. W., & Möller, T. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00012 · Cited by 409 · cited 1×
“Kynurenine is further converted to either kynurenic acid (KA) or quinolinic acid (QUIN) in astrocytes or microglia, respectively (130).”
BackgroundOlivares, D., K. Deshpande, V., Shi, Y., K. Lahiri, D., H. Greig, N., T. Rogers, J., & Huang, X. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322564 · Cited by 407 · cited 1×
“To date, drug discovery has primarily focused on indirectly boosting endogenous neurotrophic factors by antagonizing N-methyl-D-aspartate (NMDA) or potentiating alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) (185, 186).”
BackgroundQuinolinic acid: an endogenous neurotoxin with multiple targets
Lugo-Huitrón, R., Ugalde Muñiz, P., Pineda, B., Pedraza-Chaverrí, J., Ríos, C., & Pérez-de la Cruz, V. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/104024 · Cited by 394 · cited 1×
“Moreover, QUIN increases the release and blocks the reuptake of glutamate in astrocytes, thus increasing glutamatergic extracellular concentrations (132).”
BackgroundCapuron, L., Pagnoni, G., Drake, D. F., Woolwine, B. J., Spivey, J. R., Crowe, R. J., Votaw, J. R., Goodman, M. M., & Miller, A. H. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2094 · Cited by 382 · cited 1×
“Reduced activity in the ventral striatum was interrelated with reduced motivation, fatigue, and depressed mood on the neurotoxicity scale (140).”
BackgroundTh1, Th2, and Th3 cytokine alterations in major depression
MYINT, A., LEONARD, B., STEINBUSCH, H., & KIM, Y. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.07.008 · Cited by 371 · cited 1×
“Moreover, Myint and colleagues reported higher ratios of the Th1 cytokine IFN-γ/Il-4 and IFN-γ / TGF-β1 in depressed patients compared to non-depressed patients (68).”
ResultBurguillos, M. A., Svensson, M., Schulte, T., Boza-Serrano, A., Garcia-Quintanilla, A., Kavanagh, E., Santiago, M., Viceconte, N., Oliva-Martin, M. J., Osman, A. M., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.012 · Cited by 365 · cited 1×
“Gal-3 activates microglia and innate immune responses, accelerating the secretion of pro-inflammatory cytokines (43).”
BackgroundKubera, M., Lin, A.-H., Kenis, G., Bosmans, E., van Bockstaele, D., & Maes, M. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200104000-00012 · Cited by 343
The role of Nrf2 signaling in counteracting neurodegenerative diseases
Dinkova‐Kostova, A. T., Kostov, R. V., & Kazantsev, A. G. (2018) · The FEBS Journal · doi:10.1111/febs.14379 · Cited by 342 · cited 1×
“Brain Derived Neurotrophic Factor (BDNF) regulates the antioxidant gene transcription factor erythroid 2-related factor 2 (Nrf2) (108).”
BackgroundSun, Y., Koyama, Y., & Shimada, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.903455 · Cited by 304 · cited 1×
“Pro-inflammatory cytokines and astrocytic release of VEGF-A decrease the expression and assembly of claudin and occludin and increase the paracellular permeability of peripheral immune cells (83).”
BackgroundBay-Richter, C., Linderholm, K. R., Lim, C. K., Samuelsson, M., Träskman-Bendz, L., Guillemin, G. J., Erhardt, S., & Brundin, L. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.07.012 · Cited by 304 · cited 1×
“As expected, lower KA levels correlated with severe depressive symptoms and higher IL-6 levels suggesting dysregulation of the kynurenine pathway increases the risk for suicidality (133).”
BackgroundKynurenine pathway in depression: a systematic review and meta-analysis
Ogyu, K., Kubo, K., Noda, Y., Iwata, Y., Tsugawa, S., Omura, Y., Wada, M., Tarumi, R., Plitman, E., Moriguchi, S., et al. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.03.023 · Cited by 301 · cited 1×
“Meta-analyses have confirmed elevated plasma levels of QUIN in depressed patients compared to non-depressed patients (136).”
ResultBluhm, R., Williamson, P., Lanius, R., Théberge, J., Densmore, M., Bartha, R., Neufeld, R., & Osuch, E. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.02030.x · Cited by 294
Munhoz, C. D., Lepsch, L. B., Kawamoto, E. M., Malta, M. B., Lima, L. D. S., Werneck Avellar, M. C., Sapolsky, R. M., & Scavone, C. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4398-05.2006 · Cited by 274
Cortisol and major depressive disorder-translating findings from humans to animal models and Back
Nandam, L. S., Brazel, M., Zhou, M., & Jhaveri, D. J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00974 · Cited by 265 · cited 1×
“In addition, urinary free cortisol levels are approximately two times higher in depressed patients compared to non-depressed patients (18).”
BackgroundNeurotrophin signalling: novel insights into mechanisms and pathophysiology
Mitre, M., Mariga, A., & Chao, M. V. (2017) · Clinical Science · doi:10.1042/cs20160044 · Cited by 263 · cited 1×
“The activation of these multiple signaling cascades results in neuronal remodeling and adaptive circuitry functioning countering inflammation mediated neurotoxicity (184).”
Background(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.10.1253 · Cited by 262
Miller, A. H. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.08.006 · Cited by 261 · cited 1×
“Activation of MAPK increases the expression of reuptake pumps for serotonin, norepinephrine, and dopamine, subsequently decreasing the availability of monoamines at the synaptic cleft (126).”
BackgroundCobb, J. A., O’Neill, K., Milner, J., Mahajan, G. J., Lawrence, T. J., May, W. L., Miguel-Hidalgo, J., Rajkowska, G., & Stockmeier, C. A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.12.044 · Cited by 254 · cited 1×
“Similarly, postmortem studies have confirmed a reduced density of GFAPimmunoreactive astrocytes in brain tissues of patients with a history of MDD or who have completed suicide compared to controls (97).”
BackgroundInterleukin-17 in chronic inflammatory neurological diseases
Milovanovic, J., Arsenijevic, A., Stojanovic, B., Kanjevac, T., Arsenijevic, D., Radosavljevic, G., Milovanovic, M., & Arsenijevic, N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00947 · Cited by 250 · cited 5×
“IL-17 and IL-23 are central neuroinflammatory mediators, and clinical trials are currently underway examining the FIGURE 3 DAMP-PRR signaling.”
BackgroundInfluentialNrf2-dependent persistent oxidative stress results in stress-induced vulnerability to depression
Bouvier, E., Brouillard, F., Molet, J., Claverie, D., Cabungcal, J.-H., Cresto, N., Doligez, N., Rivat, C., Do, K. Q., Bernard, C., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.144 · Cited by 248 · cited 1×
“Reduced BDNF inhibits Nrf2 transcription of antioxidant enzymes and increases susceptibility to depressive behaviors in animal models (109).”
BackgroundDifferential vulnerability of central neurons of the rat to quinolinic acid
Schwarcz, R., & Köhler, C. (1983) · Neuroscience Letters · doi:10.1016/0304-3940(83)90115-5 · Cited by 239 · cited 1×
“QUIN induces neurotoxicity primarily in the striatum, the pallidal formation and the hippocampus (134).”
BackgroundDose-dependent expression of claudin-5 is a modifying factor in schizophrenia
Greene, C., Kealy, J., Humphries, M. M., Gong, Y., Hou, J., Hudson, N., Cassidy, L. M., Martiniano, R., Shashi, V, Hooper, S. R., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.156 · Cited by 235
Bai, S., Guo, W., Feng, Y., Deng, H., Li, G., Nie, H., Guo, G., Yu, H., Ma, Y., Wang, J., et al. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-320912 · Cited by 235
Zhou, Q., Hu, Y., Hua, Y., Hu, M., Luo, C., Han, X., Zhu, X., Wang, B., Xu, J., & Zhu, D. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04914.x · Cited by 225 · cited 1×
“Administering inhibitors of nNOS reversed the effects of chronic stress and increased neurogenesis (125).”
BackgroundHeat-shock proteins: chaperoning DNA repair
Dubrez, L., Causse, S., Borges Bonan, N., Dumétier, B., & Garrido, C. (2020) · Oncogene · doi:10.1038/s41388-019-1016-y · Cited by 224
Su, K.-P., Lai, H.-C., Yang, H.-T., Su, W.-P., Peng, C.-Y., Chang, J. P.-C., Chang, H.-C., & Pariante, C. M. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.01.008 · Cited by 205 · cited 2×
“Yamano and colleagues reversed INF-α induced stress susceptibility in mice with a corticotropin-releasing hormone receptor antagonist in a dose dependent fashion, suggesting that overactivity of the HPA axis mediates the cytokine depression response (64).”
BackgroundDepression and sterile inflammation: essential role of danger associated molecular patterns
Franklin, T. C., Xu, C., & Duman, R. S. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.10.025 · Cited by 204 · cited 1×
“S100 B induces neurogenesis at nanomolar concentrations and inflammation at micromolar concentrations (25).”
BackgroundEttman, C. K., Cohen, G. H., Abdalla, S. M., Sampson, L., Trinquart, L., Castrucci, B. C., Bork, R. H., Clark, M. A., Wilson, I., Vivier, P. M., et al. (2022) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2021.100091 · Cited by 204
Shu, X., Sun, Y., Sun, X., Zhou, Y., Bian, Y., Shu, Z., Ding, J., Lu, M., & Hu, G. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1813-9 · Cited by 203 · cited 1×
“Administering fluoxetine reversed the loss of GFAP-positive astrocytes and ameliorated depressive behaviors (96).”
BackgroundStress-induced neuroinflammation: role of the toll-like receptor-4 pathway
Gárate, I., Garcia-Bueno, B., Madrigal, J. L. M., Caso, J. R., Alou, L., Gomez-Lus, M. L., Micó, J. A., & Leza, J. C. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.07.005 · Cited by 202 · cited 12×
“Repeated restraint or acoustic stress exposure activates the TLR-4 pathway and increases inflammatory cytokines in the prefrontal cortex of mice.”
BackgroundInfluentialRustenhoven, J., Aalderink, M., Scotter, E. L., Oldfield, R. L., Bergin, P. S., Mee, E. W., Graham, E. S., Faull, R. L. M., Curtis, M. A., Park, T. I.-H., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0503-0 · Cited by 201 · cited 2×
“Canonical TGF-β signaling exerts anti-inflammatory neuroprotection and influences memory formation and synaptic plasticity (176).”
BackgroundCyclooxygenase-2 in synaptic signaling
Yang, H., & Chen, C. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784480144 · Cited by 195 · cited 1×
“COX-2 overexpression increases PGE-2 resulting in glutamatergic excitability, stimulation of corticotropin-releasing hormone, and the release of pro-inflammatory cytokines (159).”
Background(1996) · PubMed · Cited by 194
How inflammation affects the brain in depression: a review of functional and structural MRI studies
Han, K.-M., & Ham, B.-J. (2021) · Journal of Clinical Neurology · doi:10.3988/jcn.2021.17.4.503 · Cited by 187
Crosstalk between ER stress, autophagy and inflammation
Chipurupalli, S., Samavedam, U., & Robinson, N. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.758311 · Cited by 181 · cited 1×
“IRE-1 detects when these mechanisms are insufficient to recover protein folding and activates apoptotic and NF-κB signaling pathways leading to the transcription of inflammatory cytokines (38).”
BackgroundCaraci, F., Spampinato, S. F., Morgese, M. G., Tascedda, F., Salluzzo, M. G., Giambirtone, M. C., Caruso, G., Munafò, A., Torrisi, S. A., Leggio, G. M., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.007 · Cited by 172 · cited 1×
“Administering sertraline and venlafaxine increased serum levels of TGF-β1 and reduced depression (181).”
BackgroundKCNQ channel openers reverse depressive symptoms via an active resilience mechanism
Friedman, A. K., Juarez, B., Ku, S. M., Zhang, H., Calizo, R. C., Walsh, J. J., Chaudhury, D., Zhang, S., Hawkins, A., Dietz, D. M., et al. (2016) · Nature Communications · doi:10.1038/ncomms11671 · Cited by 172 · cited 1×
“Similarly, drug discovery is focusing on developing differentiated Kv7 potassium channel openers that generate a hyperpolarizing M-current and reduce hyperexcitability (153) (Table 1).”
BackgroundMa, K., Xu, A., Cui, S., Sun, M.-R., Xue, Y.-C., & Wang, J.-H. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.181 · Cited by 168 · cited 1×
“GABAergic neurons constitute 15 to 25% of the total neuronal population and reduced densities in the prefrontal cortices of mice is associated with major depression (144).”
BackgroundKéri, S., Szabó, C., & Kelemen, O. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.03.020 · Cited by 165 · cited 1×
“Corroborating the preclinical data, observational studies have reported that depressed patients express higher levels of TLR-4 and NF-κB in peripheral blood mononuclear cells compared to non-depressed patients (59).”
ResultToll-like receptors in the depressed and suicide brain
Pandey, G. N., Rizavi, H. S., Ren, X., Bhaumik, R., & Dwivedi, Y. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.01.021 · Cited by 164 · cited 1×
“Additionally, postmortem studies have found that mRNA expression of TLR-3 and TLR-4 is significantly increased in the dorsolateral prefrontal cortex of depressed patients compared to controls (60).”
BackgroundGiacobbe, J., Benoiton, B., Zunszain, P., Pariante, C. M., & Borsini, A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00122 · Cited by 159
NF-κB: a double-edged sword controlling inflammation
Liu, D., Zhong, Z., & Karin, M. (2022) · Biomedicines · doi:10.3390/biomedicines10061250 · Cited by 157 · cited 16×
“In clinical studies, post-endotoxin depressed mood is predicted by higher baseline activity of the NF-κB transcription factor in peripheral blood mononuclear cells (79).”
BackgroundInfluentialEvidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression.
Koo, J. W., & Duman, R. S. (2009) · PubMed · Cited by 155
Guo, J.-Y., Li, C.-Y., Ruan, Y.-P., Sun, M., Qi, X.-L., Zhao, B.-S., & Luo, F. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.03.076 · Cited by 148 · cited 1×
“Administering celecoxib, a COX-2 inhibitor, reverses the effects of chronic unpredictable stress and reduces COX-2 expression in a dose-dependent manner (162).”
BackgroundRybka, J., Kędziora-Kornatowska, K., Banaś-Leżańska, P., Majsterek, I., Carvalho, L. A., Cattaneo, A., Anacker, C., & Kędziora, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.019 · Cited by 146 · cited 2×
“The authors concluded that the oxidative inflammatory cytokine response represents a molecular pathway underpinning depression (104).”
BackgroundTherapeutic effect of exogenous hsp70 in mouse models of Alzheimer’s disease
Bobkova, N. V., Garbuz, D. G., Nesterova, I., Medvinskaya, N., Samokhin, A., Alexandrova, I., Yashin, V., Karpov, V., Kukharsky, M. S., Ninkina, N. N., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130779 · Cited by 138 · cited 7×
“HSP70 (34) HSP70 helps client proteins fold correctly and are pivotal to maintaining cellular integrity”
BackgroundInfluentialHoulton, J., Abumaria, N., Hinkley, S. F. R., & Clarkson, A. N. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00790 · Cited by 138 · cited 2×
“The primary neurotrophic factors (BDNF, NGF, and NT) reduce neuroinflammation through activation of specific tyrosine kinase receptors (TrkA TrkB, TrkC) and downstream signaling of the PKC pathway, Ras/MAPK pathway, and PI3 pathway resulting in neuronal remodeling and formation of novel synapses (183).”
BackgroundRestraint stress-induced morphological changes at the blood-brain barrier in adult rats
Sántha, P., Veszelka, S., Hoyk, Z., Mészáros, M., Walter, F. R., Tóth, A. E., Kiss, L., Kincses, A., Oláh, Z., Seprényi, G., et al. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00088 · Cited by 136 · cited 1×
“Similarly, confirmatory studies reported that the expression of claudin-5, occludin, and zo-1 were reduced in the frontal cortex and hippocampus of stress susceptible rats (85).”
BackgroundThe therapeutic potential of galectin-3 inhibition in fibrotic disease
Slack, R. J., Mills, R., & Mackinnon, A. C. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105881 · Cited by 136 · cited 1×
“Gal-3 is released into the extracellular space during the differentiation of monocytes into macrophages (42).”
BackgroundTetrahydrobioterin (BH4) pathway: from metabolism to neuropsychiatry
Fanet, H., Capuron, L., Castanon, N., Calon, F., & Vancassel, S. (2021) · Current Neuropharmacology · doi:10.2174/1570159x18666200729103529 · Cited by 134 · cited 1×
“Decreased availability of BH4, a cofactor for the rate limiting enzymes tryptophan hydroxylase and tyrosine hydroxylase, reduces the synthesis of dopamine and serotonin (127).”
BackgroundFundamental mechanisms of the cell death caused by Nitrosative stress
Wang, F., Yuan, Q., Chen, F., Pang, J., Pan, C., Xu, F., & Chen, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.742483 · Cited by 133 · cited 1×
“ONOO− inhibits energy metabolism, damages DNA, alters cytoskeletal organization, and impairs cell signal transduction (114).”
BackgroundA phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression
Nagele, P., Palanca, B. J., Gott, B., Brown, F., Barnes, L., Nguyen, T., Xiong, W., Salloum, N. C., Espejo, G. D., Lessov-Schlaggar, C. N., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe1376 · Cited by 133 · cited 1×
“The antidepressant effects of N2O are mediated through antagonism of the metabotropic glutamatergic NMDA receptors (121).”
BackgroundDavami, M., Baharlou, R., Ahmadi Vasmehjani, A., Ghanizadeh, A., Keshtkar, M., Dezhkam, I., & Atashzar, M. (2016) · Basic and Clinical Neuroscience Journal · doi:10.15412/j.bcn.03070207 · Cited by 124
Synaptic Vesicle Glycoprotein 2A: Features and Functions
Rossi, R., Arjmand, S., Bærentzen, S. L., Gjedde, A., & Landau, A. M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.864514 · Cited by 123 · cited 1×
“Furthermore, the severity of depression is inversely correlated with neuronal SV2A density and reduced GABAergic inhibitory neurotransmission (142).”
BackgroundBlood brain barrier and inflammation in depression
Medina-Rodriguez, E. M., & Beurel, E. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105926 · Cited by 123 · cited 2×
“Innate and adaptive immune responses compromise the integrity of the blood brain barrier propagating bidirectional inflammatory signals between the periphery and central nervous system (4).”
BackgroundMethodThe molecular pathophysiology of depression and the new therapeutics
Tian, H., Hu, Z., Xu, J., & Wang, C. (2022) · MedComm · doi:10.1002/mco2.156 · Cited by 122
Kandilarova, S., Stoyanov, D., Sirakov, N., Maes, M. H. J., & Specht, K. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2019.20 · Cited by 122 · cited 1×
“This is consistent with morphological and functional findings demonstrating decreased grey matter in the frontotemporal area and reduced connectivity between brain regions linked to reward processing (135).”
ResultZhang, K., Yang, C., Chang, L., Sakamoto, A., Suzuki, T., Fujita, Y., Qu, Y., Wang, S., Pu, Y., Tan, Y., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0733-x · Cited by 119 · cited 1×
“Zhang and colleagues reported that administering neutralizing antibodies to TGF-β1 blocked the antidepressant effects of (R)-ketamine in chronic social defeat stress mouse models (178).”
BackgroundKim, J., Suh, Y.-H., & Chang, K.-A. (2021) · Molecular Brain · doi:10.1186/s13041-020-00726-x · Cited by 116 · cited 1×
“In animal models, anti-IL-17 treatment rescues depression and anxiety behaviors in mice exposed to cumulative mild stress (75).”
BackgroundGriffiths, C. E. M., Fava, M., Miller, A. H., Russell, J., Ball, S. G., Xu, W., Acharya, N., & Rapaport, M. H. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000479163 · Cited by 115 · cited 1×
“The improvement in depressive symptoms correlated with reductions in CRP and the psoriasis area index (175).”
BackgroundMartino, M., Rocchi, G., Escelsior, A., & Fornaro, M. (2012) · Current Neuropharmacology · doi:10.2174/157015912800604542 · Cited by 111 · cited 8×
“IL-2 (67) IL-2 differentiates Th1 and Th2 effector cells IL-2 antibodies”
BackgroundInfluentialImmune-To-Brain Signaling: How Important are the Blood–Brain Barrier-independent Pathways?
Quan, N. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8026-z · Cited by 111
Neuronal circuits overcome imbalance in excitation and inhibition by adjusting connection numbers
Sukenik, N., Vinogradov, O., Weinreb, E., Segal, M., Levina, A., & Moses, E. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2018459118 · Cited by 109 · cited 1×
“Alternatively, inhibitory neurons hyperpolarize neurons and constrain excitatory neurotransmission (149).”
BackgroundAraya-Callís, C., Hiemke, C., Abumaria, N., & Flugge, G. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2741-x · Cited by 109
Kim, Y.-K., Kim, O. Y., & Song, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01270 · Cited by 109 · cited 2×
“Gal-3 (46) Gal-3 induces macrophages to produce and release IL-8, IL-6, and TNF- α Gal-3 inhibitors”
BackgroundMeynen, G., Unmehopa, U. A., van Heerikhuize, J. J., Hofman, M. A., Swaab, D. F., & Hoogendijk, W. J. G. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.12.010 · Cited by 108 · cited 1×
“Multiple studies have reported that AVP levels are increased in the plasma and brain nuclei of depressed patients, indicating that overactivity of AVP-V1bR dysregulates the HPA axis (21).”
BackgroundGarcia-Oscos, F., Salgado, H., Hall, S., Thomas, F., Farmer, G. E., Bermeo, J., Galindo, L. C., Ramirez, R. D., D'Mello, S., Rose-John, S., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.11.018 · Cited by 105 · cited 1×
“Garcia-Oscos and colleagues found that administration of IL-6 to cortical rat slice preparations decreased GABAergic inhibition shifting the balance to glutamatergic central hyperexcitability (143).”
BackgroundSun, Y., Wang, D., Salvadore, G., Hsu, B., Curran, M., Casper, C., Vermeulen, J., Kent, J. M., Singh, J., Drevets, W. C., et al. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.06.014 · Cited by 100 · cited 1×
“Sun and colleagues reported that antibodies to IL-6, sirukumab and siltuximab, significantly improved depressive symptoms in patients with rheumatoid arthritis or multicentric Castleman’s disease even after adjusting for disease severity, pain, and physical functioning (174).”
BackgroundVerdonk, F., Petit, A.-C., Abdel-Ahad, P., Vinckier, F., Jouvion, G., de Maricourt, P., De Medeiros, G. F., Danckaert, A., Van Steenwinckel, J., Blatzer, M., et al. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.06.033 · Cited by 99 · cited 12×
“Meta-analyses have confirmed elevated plasma levels of QUIN in depressed patients compared to non-depressed patients (136).”
BackgroundInfluentialSulforaphane produces antidepressant- and anxiolytic-like effects in adult mice
Wu, S., Gao, Q., Zhao, P., Gao, Y., Xi, Y., Wang, X., Liang, Y., Shi, H., & Ma, Y. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.12.030 · Cited by 97 · cited 2×
“Nrf2–ARE signaling (111) Nrf2–ARE signaling regulates the expression of genes that encode for proteins involved in”
BackgroundGlucocorticoid receptor-dependent astrocytes mediate stress vulnerability
Lu, C.-L., Ren, J., Mo, J.-W., Fan, J., Guo, F., Chen, L.-Y., Wen, Y.-L., Li, S.-J., Fang, Y.-Y., Wu, Z.-F., et al. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.11.022 · Cited by 97
Hulina, A., Grdić Rajković, M., Jakšić Despot, D., Jelić, D., Dojder, A., Čepelak, I., & Rumora, L. (2018) · Cell Stress and Chaperones · doi:10.1007/s12192-017-0847-0 · Cited by 92 · cited 1×
“However, under stressful conditions, HSP70 is passively and actively released into the extracellular space triggering inflammation (35).”
BackgroundKang, H.-J., Bae, K.-Y., Kim, S.-W., Kim, J.-T., Park, M.-S., Cho, K.-H., & Kim, J.-M. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.07.001 · Cited by 86 · cited 1×
“A longitudinal study following post stroke patients reported that plasma levels of IL-18 were independently associated with the development of minor and major depression (53).”
BackgroundRush, G., O’Donovan, A., Nagle, L., Conway, C., McCrohan, A., O’Farrelly, C., Lucey, J. V., & Malone, K. M. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.06.035 · Cited by 86 · cited 1×
“In contrast, despite a response, Rush and colleagues found that ECT did not normalize reduced levels of TGF-β in patients with melancholic depression (182).”
ResultSteinacker, P., Al Shweiki, M. R., Oeckl, P., Graf, H., Ludolph, A. C., Schönfeldt-Lecuona, C., & Otto, M. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.09.012 · Cited by 84 · cited 1×
“/ml, distinguished MDD from bipolar disorder and schizophrenia with a sensitivity and specificity of 87 and 70%, respectively (99).”
BackgroundGSK3β: a master player in depressive disorder pathogenesis and treatment responsiveness
Duda, P., Hajka, D., Wójcicka, O., Rakus, D., & Gizak, A. (2020) · Cells · doi:10.3390/cells9030727 · Cited by 84
Wu, D., Zhang, G., Zhao, C., Yang, Y., Miao, Z., & Xu, X. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.04.004 · Cited by 83 · cited 1×
“Moreover, Wu and colleagues found that injecting recombinant mouse IL-18 into the amygdala increased depressive-like behaviors, which was reversed with an IL-18R antagonist (52).”
BackgroundNeuroinflammatory basis of depression: learning from experimental models
Afridi, R., & Suk, K. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.691067 · Cited by 82 · cited 1×
“Mounting evidence supports that gliosis is associated with increased levels of proinflammatory cytokines and reactive oxygen and nitrogen species (RONS) in subcortical limbic brain regions implicated in depression (89).”
BackgroundRecurrence of depressive disorders after interferon-induced depression
Chiu, W.-C., Su, Y.-P., Su, K.-P., & Chen, P.-C. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.274 · Cited by 80 · cited 15×
“Kubera and colleagues reported that monoamine-based antidepressants increased IL-10, a negative immunoregulator of IFN-γ, suggesting that the therapeutic efficacy of antidepressants may be related to their immunoregulatory effects on pro-inflammatory cytokines (69).”
BackgroundInfluentialMartín-Hernández, D., Caso, J. R., Javier Meana, J., Callado, L. F., Madrigal, J. L. M., García-Bueno, B., & Leza, J. C. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1294-2 · Cited by 80
Increased GFAP concentrations in the cerebrospinal fluid of patients with unipolar depression
Michel, M., Fiebich, B. L., Kuzior, H., Meixensberger, S., Berger, B., Maier, S., Nickel, K., Runge, K., Denzel, D., Pankratz, B., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01423-6 · Cited by 79 · cited 1×
“org depression compared to controls, indicative of astroglia injury (98).”
BackgroundYao, R., Pan, R., Shang, C., Li, X., Cheng, J., Xu, J., & Li, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00986 · Cited by 79 · cited 1×
“Translocator protein 18 kDa (TSPO) is expressed on the outer mitochondrial membrane of M1 microglia and is an indirect measure of microglial activation and neuroinflammation (91).”
BackgroundJha, M. K., Minhajuddin, A., Gadad, B. S., Greer, T. L., Mayes, T. L., & Trivedi, M. H. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.07.005 · Cited by 79 · cited 1×
“Treatment with a bupropionSSRI combination reverses dopaminergic neuronal loss and ameliorates depression indicating that IL-17 predicts bupropionSSRI combination response (72).”
BackgroundDetka, J., & Głombik, K. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00274-8 · Cited by 79 · cited 1×
“Furthermore, emerging data supports that glucagon-like peptide-1 (GLP-1) agonists, such as liraglutide, have pro-cognitive, neuroprotective, and antidepressant effects (32).”
BackgroundStatin use and risk of depression: a Swedish national cohort study
Redlich, C., Berk, M., Williams, L. J., Sundquist, J., Sundquist, K., & Li, X. (2014) · BMC Psychiatry · doi:10.1186/s12888-014-0348-y · Cited by 76 · cited 1×
“A large Swedish national cohort study confirmed that statins reduced the odds of depression by 8% compared to placebo, but a subgroup analysis found that only simvastatin significantly reduced the odds of depression (172).”
BackgroundChaaya, C., Thambi, V. D., Sabuncu, Ö., Abedi, R., Osman, A. O. A., Uwishema, O., & Onyeaka, H. N. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.104033 · Cited by 75 · cited 2×
“Several pathways to cross the BBB have been described: (1) Entering the brain parenchyma through leaky capillaries in the circumventricular organs and choroid plexus, (2) Direct transportation into the CNS, (3) Binding to vagal afferents and entering the brain, and (4) Direct cellular trafficking (84).”
BackgroundMethodJorgensen, A., Krogh, J., Miskowiak, K., Bolwig, T. G., Kessing, L. V., Fink-Jensen, A., Nordentoft, M., Henriksen, T., Weimann, A., Poulsen, H. E., et al. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.02.011 · Cited by 74 · cited 1×
“Moreover, greater symptoms of depression are positively correlated with higher urinary levels of oxidatively damaged DNA and RNA products (105).”
BackgroundProgress in PET imaging of Neuroinflammation targeting COX-2 enzyme
Prabhakaran, J., Molotkov, A., Mintz, A., & Mann, J. J. (2021) · Molecules · doi:10.3390/molecules26113208 · Cited by 74
Wang, Y., Xu, J., Liu, Y., Li, Z., & Li, X. (2018) · Neural Plasticity · doi:10.1155/2018/7254016 · Cited by 71 · cited 1×
“The depressive-like behaviors were reversed with a TLR4 antagonist suggesting that hyperactive TLR4-NF-κB signaling is involved in the pathogenesis of depression (77).”
BackgroundAbbasi, S. H., Mohammadinejad, P., Shahmansouri, N., Salehiomran, A., Beglar, A. A., Zeinoddini, A., Forghani, S., & Akhondzadeh, S. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.04.049 · Cited by 70
Unemura, K., Kume, T., Kondo, M., Maeda, Y., Izumi, Y., & Akaike, A. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12047fp · Cited by 69 · cited 1×
“Overall, the data suggest that aberrant glucocorticoid signaling mediates the relationship between the stress response, inflammation, and depression (15).”
BackgroundDexamethasone suppression test May predict more severe/violent suicidal behavior
Alacreu-Crespo, A., Olié, E., Guillaume, S., Girod, C., Cazals, A., Chaudieu, I., & Courtet, P. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00097 · Cited by 68 · cited 1×
“Low dose dexamethasone suppresses the release of cortisol and failure to do so is diagnostic of HPA axis hyperactivity and hypercortisolism (17).”
BackgroundMiller, A. H., & Raison, C. L. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01887-y · Cited by 67 · cited 1×
“Pharmacotherapies antagonizing the GR and inhibiting cortisol synthesis have been developed, however, their efficacy has been stymied by phenotypic and genotypic diagnostic heterogeneities (20).”
BackgroundNitric oxide signalling and antidepressant action revisited
Joca, S. R. L., Sartim, A. G., Roncalho, A. L., Diniz, C. F. A., & Wegener, G. (2019) · Cell and Tissue Research · doi:10.1007/s00441-018-02987-4 · Cited by 63 · cited 1×
“Oliveira and colleagues found increased nNOS CA1 hippocampal immunoreactivity whereas Bernstein and colleagues found reduced nNOS locus coeruleus immunoreactivity in postmortem samples of depressed patients (123).”
BackgroundGlucocorticoid receptor gene methylation and HPA-axis regulation in adolescents. The TRAILS study
van der Knaap, L. J., Oldehinkel, A. J., Verhulst, F. C., van Oort, F. V. A., & Riese, H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.04.012 · Cited by 60
Narsapur (1983) · doi:10.1016/0165-0327(83)90008-3 · Cited by 59 · cited 3×
“RNS (118) NO is a second messenger with pleiotropic effects, and at excessive concentrations”
Dean, O. M., Maes, M., Ashton, M., Berk, L., Kanchanatawan, B., Sughondhabirom, A., Tangwongchai, S., Ng, C., Dowling, N., Malhi, G. S., et al. (2014) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2014.12.3.180 · Cited by 58
Timberlake, M. A., & Dwivedi, Y. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00319 · Cited by 58 · cited 1×
“org GRP94 gene expression were higher in the hippocampus of rats with learned helplessness compared to rats without learned helplessness (39).”
Background(2015) · Europe PMC (PubMed Central) · Cited by 58
Sigma-1 receptor: a potential therapeutic target for traumatic brain injury
Shi, M., Chen, F., Chen, Z., Yang, W., Yue, S., Zhang, J., & Chen, X. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.685201 · Cited by 58 · cited 1×
“ER membranes express sigma-1 receptors (sig-1R), and preliminary preclinical data suggest that induction of sig-1R alleviates ER stress and represses apoptotic signaling pathways (41).”
BackgroundMischoulon, D., Dunlop, B. W., Kinkead, B., Schettler, P. J., Lamon-Fava, S., Rakofsky, J. J., Nierenberg, A. A., Clain, A. J., Crowe, T. M., Wong, A., et al. (2022) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.21m14074 · Cited by 56 · cited 3×
“A dose finding study comparing 1 g, 2 g, or 4 g of omega-fatty acid capsules with a 4:1 ratio of EPA:DPA reported that high-doses (4 g/per day) were required for antidepressant efficacy in overweight or obese patients with inflammation (156).”
BackgroundReduced inhibition in depression impairs stimulus processing in human cortical microcircuits
Yao, H. K., Guet-McCreight, A., Mazza, F., Moradi Chameh, H., Prevot, T. D., Griffiths, J. D., Tripathy, S. J., Valiante, T. A., Sibille, E., & Hay, E. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110232 · Cited by 55
Majd, M., Hashemian, F., Hosseini, S., Shariatpanahi, M. V., & Sharifi, A. (2015) · Iranian journal of pharmaceutical research · doi:10.22037/ijpr.2015.1637 · Cited by 55
Transcriptomic predictors of inflammation-induced depressed mood
Cho, J. H.-J., Irwin, M. R., Eisenberger, N. I., Lamkin, D. M., & Cole, S. W. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0316-9 · Cited by 54
Oxidative and Nitrosative stress in major depressive disorder: a case control study
Somani, A., Singh, A. K., Gupta, B., Nagarkoti, S., Dalal, P. K., & Dikshit, M. (2022) · Brain Sciences · doi:10.3390/brainsci12020144 · Cited by 54 · cited 1×
“Reduced plasma levels of antioxidants (vitamin E, zinc, coenzyme Q10, glutathione) and enzymes (xanthine oxidase and superoxide dismutase) are interrelated with worsening depressive symptoms (102).”
BackgroundWu, H., Lv, W., Pan, Q., Kalavagunta, P. K., Liu, Q., Qin, G., Cai, M., Zhou, L., Wang, T., Xia, Z., et al. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.09.022 · Cited by 54 · cited 1×
“Simvastatin treatment in high fat diet or streptozotocin-induced diabetic mice has been shown to rescue depressive-like behaviors, and restore the expression of 5-HT receptors, BDNF, and anti-inflammatory cytokines in the hippocampus (168).”
BackgroundResting-state functional connectivity of salience network in schizophrenia and depression
Huang, H., Chen, C., Rong, B., Wan, Q., Chen, J., Liu, Z., Zhou, Y., Wang, G., & Wang, H. (2022) · Scientific Reports · doi:10.1038/s41598-022-15489-9 · Cited by 53 · cited 1×
“The salience network is important for regulating emotion and cognition, and functional deficits correlate with impairments of cognition and emotion regulation in depression (150).”
BackgroundMaes, M., Mihaylova, I., Kubera, M., Leunis, J.-C., Twisk, F. N. M., & Geffard, M. (2012) · Metabolic Brain Disease · doi:10.1007/s11011-012-9316-8 · Cited by 52 · cited 1×
“These autoimmune responses dysregulate key cellular functions and are thought to play a role in the neuroprogression of inflammation and depression (106).”
BackgroundDe Giorgi, R., De Crescenzo, F., Rizzo Pesci, N., Martens, M., Howard, W., Cowen, P. J., & Harmer, C. J. (2021) · PLOS ONE · doi:10.1371/journal.pone.0249409 · Cited by 52 · cited 1×
“A meta-analysis of RCTs found that the addition of a statin to an antidepressant had a moderate effect on reducing depressive scores compared to placebo at week 8 and 12 with no report of serious adverse events across all trials (170).”
BackgroundLiu, Z., Chen, H.-Q., Huang, Y., Qiu, Y.-H., & Peng, Y.-P. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.08.006 · Cited by 51
Effect of toll-like receptor 4 on depressive-like behaviors induced by chronic social defeat stress
Zhang, K., Lin, W., Zhang, J., Zhao, Y., Wang, X., & Zhao, M. (2020) · Brain and Behavior · doi:10.1002/brb3.1525 · Cited by 50 · cited 1×
“Administering fluoxetine reduced the expression of TLR-4 and reversed the depressive phenotype (58).”
BackgroundBrivaracetam augments short‐term depression and slows vesicle recycling
Yang, X., Bognar, J., He, T., Mohammed, M., Niespodziany, I., Wolff, C., Esguerra, M., Rothman, S. M., & Dubinsky, J. M. (2015) · Epilepsia · doi:10.1111/epi.13223 · Cited by 47
Gazal, M., Souza, L. D., Fucolo, B. A., Wiener, C. D., Silva, R. A., Pinheiro, R. T., Jansen, K., Ghislene, G., Oses, J. P., & Kaster, M. P. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.03.002 · Cited by 47 · cited 1×
“Normalizing immune signaling, cytokine expression, and the nitro-oxidative balance reduces the severity of depression (7).”
BackgroundCirculating T helper 17 and IFN-γ positive Th17 cells in Major Depressive Disorder
Ghosh, R., Kumar, P. K., Mitra, P., Purohit, P., Nebhinani, N., & Sharma, P. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112811 · Cited by 47 · cited 1×
“Elevated serum levels of Th1 and Th17 cells along with a decrease in Treg cells have been reported in depression (66).”
BackgroundGuimarães, M. C., Guimarães, T. M., Hallak, J. E., Abrão, J., & Machado-de-Sousa, J. P. (2021) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2020-1543 · Cited by 42 · cited 1×
“Preliminary evidence supports that inhaled N2O improves treatment-resistant depressive symptoms (120).”
BackgroundBouvier, E., Brouillard, F., Molet, J., Claverie, D., Cabungcal, J.-H., Cresto, N., Doligez, N., Rivat, C., Do, K. Q., Bernard, C., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.211 · Cited by 42
Biology of cyclooxygenase-2: An application in depression therapeutics
He, Y., Han, Y., Liao, X., Zou, M., & Wang, Y. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1037588 · Cited by 42
Li, X., Wilder‐Smith, C. H., Kan, M. E., Lu, J., Cao, Y., & Wong, R. K. M. (2014) · PubMed · Cited by 39
Meta-analysis of molecular imaging of translocator protein in major depression
Eggerstorfer, B., Kim, J.-H., Cumming, P., Lanzenberger, R., & Gryglewski, G. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.981442 · Cited by 35
Vasopressin V1B receptor antagonists as potential antidepressants
Chaki, S. (2021) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab013 · Cited by 34 · cited 1×
“Thus far, the antidepressant effects of V1bR antagonists in small clinical trials are mixed but show efficacy signals in patients with overactive HPA activity (22) (Figure 2).”
BackgroundSutinen, E. M., Korolainen, M. A., Häyrinen, J., Alafuzoff, I., Petratos, S., Salminen, A., Soininen, H., Pirttilä, T., & Ojala, J. O. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00214 · Cited by 34 · cited 1×
“Activated microglia upregulate IL-18, which increases glycogen synthase kinase (GSK-3β) and IFNγ-dependent IDO expression in glial cells (129).”
BackgroundWang, C.-H., Gu, J.-Y., Zhang, X.-L., Dong, J., Yang, J., Zhang, Y.-L., Ning, Q.-F., Shan, X.-W., & Li, Y. (2016) · Behavioral and Brain Functions · doi:10.1186/s12993-016-0116-x · Cited by 33 · cited 1×
“Venlafaxine reduced hippocampal S100b expression and reversed depressive-like behavior suggesting that high levels of S100b predict the risk for depression and antidepressant response (26).”
BackgroundDepression in type 1 diabetes was associated with high levels of circulating galectin-3
Melin, E. O., Dereke, J., Thunander, M., & Hillman, M. (2018) · Endocrine Connections · doi:10.1530/ec-18-0108 · Cited by 31 · cited 1×
“Observational studies in diabetic and obese patients have found that depression is linked to higher levels of gal-3, inflammatory cytokines, and parallel dysregulation of glucose metabolism (44).”
BackgroundOxygen metabolism by neuronal nitric-oxide synthase
Gao, Y. T., Panda, S. P., Roman, L. J., Martásek, P., Ishimura, Y., & Masters, B. S. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609814200 · Cited by 30 · cited 1×
“NO is synthesized from oxygen dependent l-arginine by nNOS in glial cells (116).”
BackgroundYamano, M., & Tohyama, M. (1994) · Neuroscience Research · doi:10.1016/0168-0102(94)90080-9 · Cited by 30 · cited 1×
“Yamano and colleagues reversed INF-α induced stress susceptibility in mice with a corticotropin-releasing hormone receptor antagonist in a dose dependent fashion, suggesting that overactivity of the HPA axis mediates the cytokine depression response (64).”
BackgroundQuinolinic acid and glutamatergic neurodegeneration in Caenorhabditis elegans
da Silveira, T. L., Zamberlan, D. C., Arantes, L. P., Machado, M. L., da Silva, T. C., Câmara, D. D. F., Santamaría, A., Aschner, M., & Soares, F. A. A. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2018.04.015 · Cited by 30
Wei, Y., Chang, L., & Hashimoto, K. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.04.010 · Cited by 30 · cited 9×
“Anti-Inflammatory Mediators Anti-inflammatory Role Emerging therapeutics TGF-β1 (179) TGF-β1 promotes neurogenesis and plasticity Intranasal administration of recombinant TGF-β1 Superoxide dismutase (104) Superoxide dismutase is an antioxidant enzyme that catalyzes the dismutation of superoxide radicals to either mole…”
BackgroundInfluentialHai-Na, Z., Xu-Ben, Y., Cong-Rong, T., Yan-Cheng, C., Fan, Y., Lei-Mei, X., Ruo-Lan, S., Ye-Zi, Ye-Xuan, W., & Jing, L. (2020) · Psychopharmacology · doi:10.1007/s00213-019-05406-w · Cited by 29
King, D. R., Salako, D. C., Arthur-Bentil, S. K., Rubin, A. E., Italiya, J. B., Tan, J. S., Macris, D. G., Neely, H. K., Palka, J. M., Grodin, J. L., et al. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.12.050 · Cited by 29 · cited 1×
“Moreover, King and colleagues reported that higher levels of Gal-3 were associated with greater depressive symptoms in a community-based sample of patients with heart failure and stroke (45).”
BackgroundIncreased inflammation in depression: a little in all, or a lot in a few?
Pariante, C. M. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2021.21101043 · Cited by 24 · cited 1×
“There is no unifying diagnostic criteria for depression associated with inflammation, however a peripheral C-reactive protein (CRP) level exceeding 3 mg/L is commonly used as a marker of subtyping inflammation (8).”
BackgroundLiu, W., Li, Q., Ye, B., Cao, H., Shen, F., Xu, Z., Du, W., Guo, F., Liu, J., Li, T., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00837 · Cited by 24 · cited 1×
“NO is a second messenger with pleiotropic effects, and at excessive concentrations, overstimulates the NMDA receptor precipitating excitotoxicity (117).”
BackgroundTwo-year US Pharmacovigilance report on Brodalumab
Lebwohl, M., Leonardi, C., Wu, J. J., Armstrong, A., Rawnsley, N., Merchant, M., Alexander, B., & Jacobson, A. (2021) · Dermatology and Therapy · doi:10.1007/s13555-020-00472-x · Cited by 24 · cited 1×
“A thorough investigation later revealed there was no causal link between Brodalumab and suicidal behaviors (74).”
BackgroundDu, X., Zou, S., Yue, Y., Fang, X., Wu, Y., Wu, S., Wang, H., Li, Z., Zhao, X., Yin, M., et al. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04176-8 · Cited by 23
Vakhitova, Y. V., Kalinina, T. S., Zainullina, L. F., Lusta, A. Y., Volkova, A. V., Kudryashov, N. V., Gudasheva, T. A., Shimshirt, A. A., Kadnikov, I. A., Voronin, M. V., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413381 · Cited by 21 · cited 1×
“Two BDNF mimickers currently under investigation are dipeptide N-monosuccinyl-L-seryl-L-lysine and 7,8-Dihydroxyflavone (187).”
BackgroundChang, J. P.-C., Lai, H.-C., Yang, H.-T., Su, W.-P., Peng, C.-Y., Gałecki, P., Walczewska, A., Pariante, C. M., & Su, K.-P. (2017) · Nutritional Neuroscience · doi:10.1080/1028415x.2015.1123378 · Cited by 19
Association of S100B Serum Levels with Metabolic Syndrome and its Components
Kheirouri, S., Ebrahimi, E., & Alizadeh, M. (2018) · Acta Médica Portuguesa · doi:10.20344/amp.9073 · Cited by 19 · cited 1×
“Diabetes, hypertension, high cholesterol, and metabolic syndrome (29).”
BackgroundKecskés, M., Henn-Mike, N., Agócs-Laboda, Á., Szőcs, S., Petykó, Z., & Varga, C. (2020) · Communications Biology · doi:10.1038/s42003-020-01496-x · Cited by 18 · cited 1×
“Confirmatory post-mortem studies in depressed patients have found reduced somatostatin gene expression in the subgenual anterior cingulate cortex (146).”
BackgroundDogan, K. H., Unaldi, M., & Demirci, S. (2016) · Journal of Forensic Sciences · doi:10.1111/1556-4029.13124 · Cited by 18 · cited 1×
“In addition, S100B has been linked to suicide, and Dogan and colleagues found that CSF levels of S100B were higher in completed suicide autopsy cases compared to controls (27).”
BackgroundKalkman, H. O. (2023) · Biomedicines · doi:10.3390/biomedicines11030806 · Cited by 18
Jovanovic, A. M., Mitkovic-Voncina, M., Kostic, M., Jeremic, M., Todorovic, J., Popadic, D., Tosevski, D. L., & Markovic, I. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113987 · Cited by 16 · cited 1×
“Preliminary evidence supports that childhood maltreatment mediates a higher concentration of TGFβ1 in adults with major depressive disorder suggesting an epigenetic role for TGFβ1 in stress related disorders (180).”
BackgroundZHONG, J.-M., WU, S.-Y., BAI, J., GUO, Q., TAO, J., CHEN, H., ZHAO, N.-W., ZHAO, Z., & FU, H. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.669 · Cited by 14 · cited 1×
“In clinical studies, the relationship between serum Hsp70 and depression is not precise with variable findings between serum levels of HSP70 and depressive symptoms (36).”
BackgroundThe anti-depressant effects of a novel PDE4 inhibitor derived from resveratrol
Yu, Y., Wang, J., & Huang, X. (2021) · Pharmaceutical Biology · doi:10.1080/13880209.2021.1907422 · Cited by 14 · cited 3×
“PDE-4 (87) PDE-4 hydrolyzes and inactivates intracellular cAMP, which is a second messenger that”
BackgroundShao, J., Meng, L., Yang, Z., Yu, P., Song, L., Gao, Y., Gong, M., Meng, C., & Shi, H. (2020) · NeuroReport · doi:10.1097/wnr.0000000000001415 · Cited by 14
Steiner, J., Bernstein, H.-G., Schiltz, K., Haase, T., Meyer-Lotz, G., Dobrowolny, H., Müller, U. J., Martins-de-Souza, D., Borucki, K., Schroeter, M. L., et al. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.10.001 · Cited by 13
Imaizumi, T., Toda, T., Maekawa, M., Sakurai, D., Hagiwara, Y., Yoshida, Y., Ando, M., & Maruyama, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-22048-9 · Cited by 12 · cited 1×
“5 times more likely to use antidepressants compared to patients without metabolic syndrome (30).”
BackgroundUrine 3-Nitrotyrosine and serum HDL as potential biomarkers of depression
Nobis, A., Zalewski, D., Samaryn, E., Maciejczyk, M., Zalewska, A., & Waszkiewicz, N. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12010377 · Cited by 12 · cited 1×
“Urine levels of 3-NT are higher in depressed compared to non-depressed patients, implying that nitrosative stress is a major contributor to cytokine induced depression (115).”
BackgroundNeuronal nitric oxide synthase regulates depression-like behaviors in shortening-induced obese mice
Wang, P., Kong, F.-Z., Hong, X.-H., Zhang, L., Zhao, W.-H., Yang, J.-C., & Zhang, H. (2022) · Nutrients · doi:10.3390/nu14204302 · Cited by 11 · cited 1×
“Preclinical work supports that administration of nNOS inhibitors, such as 7-nitroindole, reduces depressive-like behaviors in obese mice (124).”
Schiweck, C., Aichholzer, M., Reif, A., & Thanarajah, S. E. (2022) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2022.100454 · Cited by 11 · cited 14×
“IL-17 (73) IL-17 activates astrocytes, microglia, and endothelial cells to release cytokines and”
BackgroundInfluentialFerentinos, P., Maratou, E., Antoniou, A., Serretti, A., Smyrnis, N., & Moutsatsou, P. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.801738 · Cited by 7 · cited 1×
“Moreover, Ferentinos and colleagues reported that depression severity correlated with higher serum levels of IL-1β (51).”
BackgroundCombined effects of multiple endoplasmic reticulum stresses on cytokine secretion in macrophage
Kim, H.-M., Do, C.-H., & Lee, D.-H. (2012) · Biomolecules and Therapeutics · doi:10.4062/biomolther.2012.20.3.346 · Cited by 5 · cited 18×
“Moreover, Kim and colleagues found that macrophage cell lines treated with tunicamycin increased the expression of ER stress markers, GRP94 and GRP78, and secretion of IL-6 (40).”
BackgroundInfluential
Cited by
PI3K/AKT signaling pathway: Molecular mechanisms and therapeutic potential in depression
Guo, N., Wang, X., Xu, M., Bai, J., Yu, H., & Zhang, L. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107300 · Cited by 218
Effects of chronic stress on cognitive function – From neurobiology to intervention
Girotti, M., Bulin, S. E., & Carreno, F. R. (2024) · Neurobiology of Stress · doi:10.1016/j.ynstr.2024.100670 · Cited by 206
“We refer the interested reader to comprehensive reviews on the subject (Carrier et al., 2021; Godoy et al., 2018; Gray et al., 2017; Hassamal 2023; McEwen and Akil 2020).”
MethodSharma, S., Chawla, S., Kumar, P., Ahmad, R., & Verma, P. K. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149123 · Cited by 107
Treatment-resistant depression: molecular mechanisms and management
Kajumba, M. M., Kakooza‐Mwesige, A., Nakasujja, N., Attix, D. K., & Canli, T. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00205-y · Cited by 103
“The resulting DA and NE deficiency is associated with treatment‑resistant somatic symptoms subsequent desensitization of the HPA axis [139].”
BackgroundDepression and coronary heart disease: mechanisms, interventions, and treatments
Xu, L., Zhai, X., Shi, D., & Zhang, Y. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1328048 · Cited by 97
Metadata
- Authors
- Hassamal, S.
- Affiliations
- California University of Science and Medicine (US)
- Corresponding author
- Hassamal, Sameer
- ORCID
- Hassamal, Sameer
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2023-05-11
- Volume
- 14
- Pages
- 1130989-1130989
- ISSN
- 1664-0640 (ISSN-L)
- PMC
- PMC10213648
- OpenAlex
- W4376279472
- Semantic Scholar
- 38bc0fd145aaecf15f84b2c481c52f74bd9d9788
- Cited by
- 578
- References
- 194
- Citations by year
- 2026: 223 · 2025: 239 · 2024: 103 · 2023: 13
- FWCI
- 11.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Psychiatry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- chronic stress, neuroinflammation, depression, major depressive disorder, HPA axis dysregulation, glucocorticoid resistance, peripheral inflammation, cytokines, blood-brain barrier, microglial activation, glial cells, hippocampal volume, ventral striatum, ventromedial prefrontal cortex, nitro-oxidative stress, inflammatory markers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.